A new SARS-CoV-2 variant, Nimbus or NB.1.8.1, is drawing attention due to rising transmission in parts of Asia.

Chronic heart failure and hypoalbuminaemia are linked to a poor antibody response at 3 months after the third dose of the ...

FDA vaccines chief Vinay Prasad limited broader use of COVID vaccines, citing reduced risk and data concerns. Read more here.

Since the emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), understanding the mechanisms underlying ...

Scientists have uncovered a stealthy tactic used by the SARS-CoV-2 virus: one of its proteins can leap from infected cells to ...

A study published in mBio details the vulnerability of coronaviruses to inhibitors of a small protein domain called Mac1, or ...

New WHO report suggests COVID-19 originated from animal-to-human transmission, though Director-General Tedros maintains all ...

The use of TNF-α inhibitors among patients with hidradenitis suppurativa did not affect seroconversion following mRNA vaccination for COVID-19.

SARS-CoV-2 infection in children and adolescents increases risk for cardiovascular disease, compared with uninfected individuals.

Covid has largely dropped out of the headlines, but the virus that causes it is still circulating. We ask what we should know about a new variant of SARS-CoV-2, the state of the Covid pandemic in 2025 ...